Terms: = Sarcomas AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
18 results:
1. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
[TBL] [Abstract] [Full Text] [Related]
2. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G
Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336
[TBL] [Abstract] [Full Text] [Related]
3. The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis.
Kokkali S; Kotsantis I; Magou E; Sophia T; Kormas T; Diakoumis G; Spathas N; Psyrri A; Ardavanis A
Invest New Drugs; 2022 Jun; 40(3):668-675. PubMed ID: 35312944
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of Secondary sarcomas Among Patients With Cancer of the Abdomen or Pelvis Who Received Combinations of Surgery, Radiation, and Chemotherapy vs Surgery Alone.
Hird AE; Magee DE; Matta R; Saskin R; Dvorani E; Kulkarni GS; Kodama R; Herschorn S; Narod SA; Nam RK
JAMA Netw Open; 2020 Oct; 3(10):e2013929. PubMed ID: 33006617
[TBL] [Abstract] [Full Text] [Related]
5. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and treatment.
Wang B; Chen LJ; Wang XY
Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21).
Hu G; Lu A; Wu J; Jia Y; Zuo Y; Ding M; Zhang L
Pediatr Hematol Oncol; 2021 Feb; 38(1):14-24. PubMed ID: 32803999
[TBL] [Abstract] [Full Text] [Related]
7. Racial Differences in Extremity Soft Tissue Sarcoma treatment in a Universally Insured Population.
Pak LM; Kwon NK; Baldini EH; Learn PA; Koehlmoos T; Haider AH; Raut CP
J Surg Res; 2020 Jun; 250():125-134. PubMed ID: 32044509
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric runx1-runx1T1 (+) Acute Myeloid Leukemia.
Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.
Claerhout H; Van Aelst S; Melis C; Tousseyn T; Gheysens O; Vandenberghe P; Dierickx D; Boeckx N
Eur J Haematol; 2018 Jun; 100(6):603-612. PubMed ID: 29532520
[TBL] [Abstract] [Full Text] [Related]
10. Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/runx1-runx1T1 Rearrangement.
Tokunaga K; Yamamura A; Ueno S; Kikukawa Y; Yamaguchi S; Hidaka M; Matsuno N; Kawaguchi T; Matsuoka M; Okuno Y
Intern Med; 2018 Feb; 57(4):563-568. PubMed ID: 29151502
[TBL] [Abstract] [Full Text] [Related]
11. Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.
Villa G; Hernández-Pastor LJ; Guix M; Lavernia J; Cuesta M
Clin Transl Oncol; 2015 Jan; 17(1):24-33. PubMed ID: 24981588
[TBL] [Abstract] [Full Text] [Related]
12. Co-occurrence of second primary malignancy in patients with thyroid cancer.
Hsu CH; Huang CL; Hsu YH; Iqbal U; Nguyen PA; Jian WS
QJM; 2014 Aug; 107(8):643-8. PubMed ID: 24623860
[TBL] [Abstract] [Full Text] [Related]
13. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract] [Full Text] [Related]
14. Isolated recurrence of granulocytic sarcoma manifesting as extra- and intracranial masses--case report.
Nishimura S; Kyuma Y; Kamijo A; Maruta A
Neurol Med Chir (Tokyo); 2004 Jun; 44(6):311-6. PubMed ID: 15253547
[TBL] [Abstract] [Full Text] [Related]
15. Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience.
Rubnitz JE; Raimondi SC; Halbert AR; Tong X; Srivastava DK; Razzouk BI; Pui CH; Downing JR; Ribeiro RC; Behm FG
Leukemia; 2002 Oct; 16(10):2072-7. PubMed ID: 12357359
[TBL] [Abstract] [Full Text] [Related]
16. Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing's sarcoma.
Lesesve JF; Schneider P; Dolgopolov I; Bastard C; Lenormand B; Cambon-Michot E; Callat MP; Cavelier B; Tron PH; Vannier JP
Med Pediatr Oncol; 1997 Aug; 29(2):132-4. PubMed ID: 9180915
[TBL] [Abstract] [Full Text] [Related]
17. Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia.
Thalhammer F; Gisslinger H; Chott A; Haas O; Etele-Hainz A; Helbich T; Kusec R; Linkesch W; Simonitsch I; Strobl H
Ann Hematol; 1994 Feb; 68(2):97-9. PubMed ID: 8148423
[TBL] [Abstract] [Full Text] [Related]
18. [HLA phenotype in patients with osteosarcoma].
Shimizu T
Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):269-73. PubMed ID: 2738427
[TBL] [Abstract] [Full Text] [Related]
